MedPath

Effect of supplementation in treatment of women with gestational diabetes

Phase 3
Conditions
Gestational diabetes.
Diabetes mellitus in pregnancy, unspecified
E28.2
Registration Number
IRCT201611115623N91
Lead Sponsor
Vice chancellor for research, Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

Patients with gestational diabetes
Aged 18 to 40 years.

Exclusion Criteria

Placenta abruption
Pre-eclampsia
Eclampsia
Hypo and hyperthyroidism
Urinary tract infection
Smokers
Kidney or liver diseases
Insulin therapy during intervention

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hs-CRP. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Elisa kit.;Nitric oxide. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Spectrophotometry.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath